ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,770, issued on July 21, was assigned to FlagImmune (Jeollanam-do, South Korea).
"Deimmunized flagellin and vaccine composition comprising same" was invented by Joon Haeng Rhee (Gwangju, South Korea), Shee Eun Lee (Gwangju, South Korea), Koemchhoy Khim (Jeollanam-do, South Korea) and Sao Puth (Jeollanam-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: deimmunized flagellin that does not induce the production of flagellin-specific antibodies; and use thereof. In particular, the present invention relates to a flagellin variant in which a major epitope that forms an antibody against flagellin is deleted, t...